CHICAGO, USA // Michelle Abtahi Febres brings 15 years of agency expertise, driving strategic communications that address the dynamic reputational needs of healthcare clients. Her experience spans a diverse spectrum of stakeholders, including pharmaceutical companies, payers, hospital systems, and healthcarecoalitions.WitharobusttrackrecordatKetchum,Michelle’sexpertiseliesindeveloping and executing brand, marketing, and reputation strategies that deliver measurable business and reputational impact.

As a Client Director at the company, Michelle leads high-impact programs that align business objectives with meaningful industry positioning. She has also directed above-brand oncology initiatives for Novartis, Johnson & Johnson and AstraZeneca, developing audience-centric, impact- driven campaigns that amplify branded and unbranded awareness, foster stakeholder engagement, and address complex healthcare challenges. Her portfolio spans product and data communications, enterprise-wide programs, therapeutic area initiatives, and consumer healthcare launches, with expertise across therapeutic areas beyond oncology, including infectious disease and vaccines, cardiovascular disease, neuroscience, and immunology, among others.

Michelle has extensive experience partnering with advocacy and patient organizations to co-create programs that elevate patient voices, build trust, and advance shared health priorities. Guided by her passion for health equity and diversity, equity, and inclusion, she brings a personal commitment to ensuring communications reflect the needs and voices of diverse communities. As a first-generation American and the daughter of immigrants, she values creating inclusive narratives that strengthen connections and foster trust.

Based in Chicago, IL, Michelle continues to shape the future of healthcare communications—bridging business objectives with strategies that engage stakeholders and deliver lasting results.